Choo Chee Kong bought GDTC
May 13, 2026 · Form 4 insider transaction
Choo Chee Kong bought 112,000 shares of CytoMed Therapeutics Limited at $1.15 per share, a transaction worth $128.8K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 33 days after the transaction.
Direction
Acquired (buy-side)
Shares
112,000
Price
$1.15
Total value
$128.8K
InsiderChoo Chee Kong
Role—
SecurityOrdinary Shares, no par value per share
Transaction codeP: Open-market purchase
Transaction dateMay 13, 2026
Filing dateJune 15, 2026
Shares owned after430,324
OwnershipDirect
10b5-1 planNo
AmendedNo